Filtered By:
Condition: Asthma
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 47890 results found since Jan 2013.
The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy
CONCLUSION: Airway or blood type 2 inflammation status is not a valid tool for recognizing EPA or predicting asthma exacerbations in asthma patients following controller therapy.PMID:37640656 | DOI:10.1016/j.arbres.2023.07.026
Source: Archivos de Bronconeumologia - August 28, 2023 Category: Respiratory Medicine Authors: Mar ía Florencia Pilia Mar ía Jesús Cruz Donghai Ma Christian Romero-Mesones David Espejo Amaia Ojanguren Mar ía Antonia Ramon Xavier Mu ñoz I ñigo Ojanguren Source Type: research
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
CONCLUSION: In a global study, comorbidity or multimorbidity is reported in most adults with severe asthma and is associated with poorer asthma-related outcomes.PMID:37640263 | DOI:10.1016/j.anai.2023.08.021
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ghislaine Scelo Carlos A Torres-Duque Jorge Maspero Trung N Tran Ruth Murray Neil Martin Andrew N Menzies-Gow Mark Hew Matthew J Peters Peter G Gibson George C Christoff Todor A Popov Andr éanne Côté Celine Bergeron Delbert Dorscheid J Mark FitzGerald Source Type: research
The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy
CONCLUSION: Airway or blood type 2 inflammation status is not a valid tool for recognizing EPA or predicting asthma exacerbations in asthma patients following controller therapy.PMID:37640656 | DOI:10.1016/j.arbres.2023.07.026
Source: Archivos de Bronconeumologia - August 28, 2023 Category: Respiratory Medicine Authors: Mar ía Florencia Pilia Mar ía Jesús Cruz Donghai Ma Christian Romero-Mesones David Espejo Amaia Ojanguren Mar ía Antonia Ramon Xavier Mu ñoz I ñigo Ojanguren Source Type: research
Allergic rhinitis guidelines knowledge, attitudes, and practices among primary health care physicians: A national multicentre cross-sectional study
CONCLUSION: Our study demonstrates the importance of education and awareness for PHCPs managing AR. ARIA guidelines should be implemented as a standard of care for AR, as PHCPs are the first ones to encounter patients with AR, to improve outcomes and avoid undertreatment and complications.PMID:37636198 | PMC:PMC10451594 | DOI:10.4103/jfmpc.jfmpc_85_23
Source: Primary Care - August 28, 2023 Category: Primary Care Authors: Hisham Almousa Saad M Alsaad Dawood Ismail Saleh Mahjoub Sultan Bin Obaid Saad Alsaleh Source Type: research
A qualitative investigation into vaccine hesitancy and confidence among people managing allergy
Vaccine hesitancy is multifactorial, and among atopic individuals, is exacerbated by documented, but rare, cases of allergic reactions to coronavirus disease 2019 (COVID-19) vaccines.1 –3 Furthermore, conflicting information regarding the safety of COVID-19 vaccines may have caused confusion among individuals with a history of severe allergies. We performed semistructured qualitative interviews to better understand how some adults and families managing allergy perceive vaccine m essaging and what influences their decisions to be vaccinated.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ayel Luis R. Batac, Kaitlyn A. Merrill, Michael A. Golding, Elissa M. Abrams, Philippe B égin, Moshe Ben-Shoshan, Erika Ladouceur, Leslie E. Roos, Vladan Protudjer, Jennifer L.P. Protudjer Tags: Letters Source Type: research
Clinical manifestation for immunoglobulin A deficiency: a systematic review and meta-analysis
Immunoglobulin A deficiency (IgAD) is a common disease with an unknown genetic defect, characterized by the decreased or absent IgA with other isotypes normal, normal subclasses, and specific antibodies. Patie...
Source: Allergy, Asthma and Clinical Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ahmad Vosughimotlagh, Seyed Erfan Rasouli, Hosein Rafiemanesh, Molood Safarirad, Niusha Sharifinejad, Atossa Madanipour, Maria Marluce Dos Santos Vilela, Edyta Heropolita ńska-Pliszka and Gholamreza Azizi Tags: Review Source Type: research
Application of Asthma Prediction Tools in a Cohort of Infants with Severe Bronchiolitis
Pediatric Allergy, Immunology, and Pulmonology, Ahead of Print.
Source: Pediatric, Allergy, Immunology, and Pulmonology - August 28, 2023 Category: Respiratory Medicine Authors: Ronaldo C. Fabiano Filho Ruth J. Geller Ludmilla Candido Santos Janice A. Espinola Lacey B. Robinson Carlos A. Camargo Source Type: research
Academic Interest of Allergists in Atopic Dermatitis before and after Approval of Systemic Immunomodulators
Atopic dermatitis (AD) is a common inflammatory skin disease that has traditionally been managed by dermatologists. In March 2017, the United States Food and Drugs Administration (FDA) approved the first biologic, dupilumab, for the treatment of moderate-to-severe AD.1 Dupilumab is a monoclonal antibody that targets IL-4 and IL-13, which are the leading causes of allergic inflammation in various conditions including AD, asthma, eosinophilic esophagitis, and chronic rhinosinusitis with nasal polyps.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Sarah Zhang, Peck Y. Ong Tags: Letters Source Type: research
A qualitative investigation into vaccine hesitancy and confidence amongst people managing allergy
Vaccine hesitancy has a multifactorial etiology, and, among atopic individuals, is exacerbated by documented, but rare, cases of allergic reactions to COVID-19 vaccines.1 –3 Furthermore, conflicting information regarding the safety of COVID-19 vaccines may have caused confusion among individuals with history of severe allergies. We performed semi-structured qualitative interviews to better understand how some adults and families managing allergy perceive vaccine me ssaging, and what influences their decisions to be vaccinated.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ayel Luis R. Batac, Kaitlyn A. Merrill, Michael A. Golding, Elissa M. Abrams, Philippe B égin, Moshe Ben-Shoshan, Erika Ladouceur, Leslie E. Roos, Vladan Protudjer, Jennifer L.P. Protudjer Tags: Letters Source Type: research
Future of Biologics in Pediatric Asthma: Optimizing Response, Early Introduction, and Equitable Access to Treatment
To evaluate the current evidence, its limitations, and future research directions for the use of biologics in pediatric asthma, with a particular focus on the potential use of biologics to prevent pediatric asthma and equity issues in access to biologic treatment and research participation.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ianthe R.M. Schepel, Tina M. Banzon, Wanda Phipatanakul Source Type: research
Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by Dupilumab
Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant burden on patients ’ quality of life and impaired sleep quality. The most common CRSwNP endotype is characterized by type-2 inflammation, with enhanced production of interleukin (IL)-4, IL-5 and IL-13. Dupilumab is a monoclonal antibody against IL-4 receptor-alpha, which inhibits both IL-4 and IL-13 signaling, and w as recently approved for treatment of CRSwNP.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Sebastian Ferri, Carlo Montagna, Marta Casini, Luca Malvezzi, Francesca Pirola, Elena Russo, Francesca Racca, Maria Rita Messina, Francesca Puggioni, Emanuele Nappi, Giovanni Costanzo, Lorenzo Del Moro, Giuseppe Mercante, Giuseppe Spriano, Giorgio Walter Tags: Original Article Source Type: research
